Medicare Enrolled
Dr. Mukesh Kumar Delvadiya, M.D.
Internal Medicine · Plano, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Delvadiya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Delvadiya?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Delvadiya
Dr. Mukesh Kumar Delvadiya is an internal medicine specialist in Plano, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Delvadiya performed 21,378 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Delvadiya received a total of $6,924 from 66 pharmaceutical and/or device companies across 344 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Delvadiya is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 2% volume in TX
$6,924 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗21,378
Medicare services
Top 2% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
8,800 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,450 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,878 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
635 | $8 | $36 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
629 | $8 | $20 |
| Anti-nausea injection (Aloxi/palonosetron) | 430 | $1 | $114 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
371 | $133 | $496 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
234 | $90 | $368 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
199 | $10 | $64 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
179 | $12 | $108 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
165 | $7 | $29 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
162 | $5 | $24 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
153 | $98 | $707 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
110 | $22 | $157 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
93 | $13 | $60 |
| Iron level test | 93 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
93 | $8 | $35 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
90 | $49 | $344 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
72 | $46 | $313 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
64 | $19 | $99 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
60 | $91 | $357 |
| New patient office visit, complex (60-74 min) | 53 | $153 | $709 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
47 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
47 | $6 | $34 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
41 | $133 | $694 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
40 | $11 | $96 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $67 | $250 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
29 | $21 | $161 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 27 | $91 | $657 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $119 | $565 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
22 | $1,113 | $4,802 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
22 | $6 | $31 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
17 | $4 | $26 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
13 | $4 | $23 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.0% high complexity
83.4% medium
14.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,924
Total received (2018-2024)
Avg $989/year across 7 years
Top 12% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
344
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,309
2023
$1,430
2022
$1,114
2021
$133
2020
$248
2019
$235
2018
$1,454
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$722
Celgene Corporation
$278
PFIZER INC.
$191
Janssen Biotech, Inc.
$137
AstraZeneca Pharmaceuticals LP
$104
GENZYME CORPORATION
$69
SOBI, INC
$64
PharmaEssentia USA Corporation
$62
BeiGene USA, Inc.
$57
Merck Sharp & Dohme LLC
$54
E.R. Squibb & Sons, L.L.C.
$51
Karyopharm Therapeutics Inc.
$50
Daiichi Sankyo Inc.
$46
Eisai Inc.
$45
GlaxoSmithKline, LLC.
$44
ABBVIE INC.
$43
ARRAY BIOPHARMA INC
$32
Gilead Sciences, Inc.
$31
PUMA BIOTECHNOLOGY, INC.
$26
Tempus AI, Inc
$26
Incyte Corporation
$25
SpringWorks Therapeutics, Inc.
$23
Rigel Pharmaceuticals, Inc.
$22
Stemline Therapeutics Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Pharmacosmos Therapeutics Inc.
$18
Alnylam Pharmaceuticals Inc.
$17
JAZZ PHARMACEUTICALS INC.
$17
Astellas Pharma US Inc
$13
Top 3 companies account for 51.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,265
Celgene Corporation
$490
Janssen Biotech, Inc.
$395
PFIZER INC.
$382
Incyte Corporation
$374
E.R. Squibb & Sons, L.L.C.
$293
AstraZeneca Pharmaceuticals LP
$288
Amgen Inc.
$218
GENZYME CORPORATION
$191
Merck Sharp & Dohme LLC
$181
Rigel Pharmaceuticals, Inc.
$158
GlaxoSmithKline, LLC.
$153
SOBI, INC
$132
Astellas Pharma US Inc
$127
Daiichi Sankyo Inc.
$126
Eisai Inc.
$112
Gilead Sciences, Inc.
$109
Epizyme, Inc.,
$99
PharmaEssentia USA Corporation
$96
Genentech USA, Inc.
$92
TESARO, Inc.
$85
Seagen Inc.
$74
Karyopharm Therapeutics Inc.
$68
ABBVIE INC.
$64
Merck Sharp & Dohme Corporation
$62
Takeda Pharmaceuticals U.S.A., Inc.
$60
EISAI INC.
$57
BeiGene USA, Inc.
$57
Adaptive Biotechnologies Corporation
$56
Pharmacyclics LLC, An AbbVie Company
$56
GE HealthCare
$54
INSYS Therapeutics Inc
$50
ARRAY BIOPHARMA INC
$49
MEDIVATION FIELD SOLUTIONS LLC
$48
Ipsen Biopharmaceuticals, Inc
$46
Stemline Therapeutics Inc.
$42
PUMA BIOTECHNOLOGY, INC.
$40
Bayer HealthCare Pharmaceuticals Inc.
$39
Lexicon Pharmaceuticals, Inc.
$37
Myriad Genetic Laboratories, Inc.
$35
Sirtex Medical Inc
$33
Janssen Scientific Affairs, LLC
$31
Taiho Oncology, Inc.
$29
Kite Pharma, Inc.
$28
Tempus AI, Inc
$26
Lilly USA, LLC
$25
Sobi, Inc
$25
AVEO Pharmaceuticals, Inc.
$25
CTI BioPharma Corp.
$24
Regeneron Healthcare Solutions, Inc.
$24
SpringWorks Therapeutics, Inc.
$23
AbbVie, Inc.
$22
EMD Serono, Inc.
$21
Alexion Pharmaceuticals, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Exelixis Inc.
$20
ADC Therapeutics America, Inc.
$20
Blueprint Medicines Corporation
$20
Verastem, Inc.
$18
SANOFI-AVENTIS U.S. LLC
$18
Pharmacosmos Therapeutics Inc.
$18
Alnylam Pharmaceuticals Inc.
$17
JAZZ PHARMACEUTICALS INC.
$17
Foundation Medicine, Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Mylan Institutional Inc.
$12
Top 3 companies account for 31.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Abraxane · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABLIVI · CALQUENCE · CARVYKTI · CHANTIX · CREON · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · EMEND · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · FOTIVDA · Fulphila · GAZYVA · GILOTRIF · GIVLAARI · HEMLIBRA · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PIQRAY · PLUVICTO · PRECISETUMOR · PROMACTA · Padcev · Pomalyst · PreciseTumor · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · SARCLISA · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TAZVERIK · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Trodelvy · VENCLEXTA · VERZENIO · VONVENDI · Venclexta · Vonjo · XALKORI · XPOVIO · XT CDX · XTANDI · Xermelo · Xtandi · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
2,127
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Delvadiya is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Delvadiya experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Delvadiya performed 8,800 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Delvadiya receive payments from pharmaceutical companies?
Yes. Dr. Delvadiya received a total of $6,924 from 66 companies across 344 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Delvadiya's costs compare to other internal medicine physicians in Plano?
Dr. Delvadiya's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Delvadiya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Plano
Browse internal medicine physicians in Plano ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology